CMET-17. RENAL CELL CARCINOMA BRAIN METASTASES TREATED WITH STEREOTACTIC RADIATION THERAPY AND NIVOLUMAB DOES NOT ALTER LESIONAL OR CLINICAL OUTCOMES

Metastases (BM) carries the risk of hemorrhaging lesions and can be effectively treated using stereotactic radiotherapy (SRT). Nivolumab is a recently approved immunotherapy for stage IV RCC. We evaluate whether patients with RCC BM treated with SRT overlapping with nivolumab have altered clinical a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Mohammadi, Homan, Tolpin, Aaron, Figura, Nicholas, Peacock, Jeffrey, Oliver, Daniel, Sim, Austin, Palm, Russel, Ahmed, Kamran, Liu, James, Tran, Nam, Etame, Arnold, Vogelbaum, Michael, Robinson, Timothy, Yu, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
CNS Metastasis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847278/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.218
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados